ABSTRACT 48
Tendon injuries are common with poor healing potential. The paucity of therapies for tendon is due to 49 our limited understanding of the cells and molecules that drive tendon regeneration. Using a model of 50 neonatal mouse tendon regeneration, we determined the molecular basis for regeneration and identify 51
TGFβ signaling as a major pathway. Through targeted gene deletion, small molecule inhibition, and 52 lineage tracing, we elucidated TGFβ-dependent and -independent mechanisms underyling tendon 53 regeneration. Importantly, functional recovery depended on TGFβ signaling and loss of function is due 54 to impaired tenogenic cell recruitment from both Scx lin and non-Scx lin sources. We show that TGFβ 55 signaling is required directly in neonatal tenocytes for recruitment and that TGFβ is positively regulated 56 in tendons. Collectively, these results are the first to show a functional role for TGFβ signaling in tendon 57 regeneration and offer new insights toward the divergent cellular activities that may lead to 58 regenerative vs fibrotic healing. 59 60 61
INTRODUCTION 62
Tendons connect muscle to bone and function to transmit muscle forces to the skeleton. Tendon 63 function is enabled by a specialized extracellular matrix composed of highly aligned type 1 collagen 64 fibrils (Voleti, Buckley, & Soslowsky, 2012) . Although healthy tendon can normally resist high mechanical 65
loads, mechanical properties are permanently impaired after injury due to its minimally regenerative 66 potential (Voleti et al., 2012) . This loss of function can lead to chronic pain, decreased quality of life, and 67 increased risk of re-rupture. Current treatment options remain limited and there are almost no cell or 68 biological treatments to improve tendon repair or induce regeneration. 69
To date, the majority of models for tendon healing are models of scar-mediated healing since adult 70 tendon does not regenerate ( Mass & Tuel, 1991) . Although a few groups showed 72
successful tendon regeneration in model systems such as fetal sheep and MRL/MpJ mice, genetic 73 manipulation is relatively challenging in these model systems (Beredjiklian et al., 2003; Paredes, Shiovitz, 74 & Andarawis-Puri, 2018). To overcome these limitations, we previously established a model of tendon 75 regeneration using neonatal mice, that can be directly compared to adult mice within the same genetic 76
background (Howell et al., 2017) . Using lineage tracing, we found that neonatal tendon regeneration is 77 driven by tendon cell proliferation, recruitment, and differentiation leading to full functional restoration. 78 In contrast, adult tendon healing is defined by the persistent presence of myofibroblasts, absence of 79 tendon cell proliferation or recruitment, abnormal cartilage differentiation, and loss of functional 80
properties. Having identified these cellular processes distinguishing neonatal tendon healing from adult, 81
we now focus on the molecular pathways that regulate neonatal tendon regeneration. 82
Although FGF signaling was first established in chick tendon development (Brent, whether TGFβ signaling enacts a positive or negative response in the context of tendon regeneration. 101
Therefore, in this study, we determined the requirement for TGFβ signaling in neonatal tendon 102 regeneration. Using small molecule inhibition and genetic deletion experiments, we identified a role for 103
TGFβ in functional regeneration and tenogenic cell recruitment from both Scx and non-Scx lineages. 104
RESULTS 105
TGFβ signaling is activated after neonatal injury 106
To determine whether TGFβ signaling is activated after neonatal injury, we evaluated the expression of 107
TGFβ ligands (TGFβ1, 2, 3) as well as the TGFβ type II receptor (TβR2) at d3, d7, d14, and d28 post-injury 108 by qPCR. TβR2 was expressed at all time points after injury and upregulated in injured tendons relative 109
to uninjured controls at d7 and d28 (p < 0.01) (Figure 1A) . TGFβ1 and TGFβ2 expression levels were 110 transiently upregulated at alternating timepoints, however overall expression levels were quite low for 111
TGFβ2 expression (several fold lower than TGFβs 1 and 3), suggesting a relatively minor role in 112 regeneration for this ligand. By contrast, TGFβ3 expression was increased at all timepoints relative to 113 control ( Figure 1A) . To confirm active TGFβ signaling, western blot was carried out for TβR2 and 114 phospho-Smad2/3. Consistent with gene expression results, we found enhanced TβR2 and phospho-115
Smad2/3 protein in injured tendons at d14, suggesting active TGFβ signaling ( Figure 1B) . Collectively, 116
these results suggest a potential role for TGFβ signaling in neonatal tendon regeneration and suggest 117 that most of the signaling may be driven by TGFβs 1 and 3. 118 To test the requirement for TGFβ signaling in functional restoration, we inhibited TGFβ signaling for 14 128 days using the small molecule inhibitor SB-431542, which targets the TGFβ family type I receptors ALK 129 4/5/7. Pups treated with the inhibitor showed no adverse effects in growth compared to carrier-treated 130 pups and tendons appeared grossly normal (Figure S1 ). In a previous study, we determined that the 131 parameters for the brake and propel phases of gait were highly associated with Achilles tendon function 132 (Howell et al., 2017) . Carrier-treated mice fully recovered % brake and % propel gait parameters by d14, 133 consistent with functional recovery (Figure 2A) . By contrast, both % brake and % propel were impaired 134 relative to the contralateral control limb with SB-431542 treatment. We also observed a significant 135 decrease in % propel stride relative to the injured limb of carrier-treated animals. Defects in whole limb 136 gait persisted at d28 for both parameters despite cessation of inhibitor treatment from d14-d28 ( Figure  137 2B). 138
To determine the mechanical properties of the healing tissue directly, we then performed tensile testing 139 of the tendons at d28 and observed a reduction in stiffness and max force with SB-431542 treatment 140
( Figure 2C ). Mechanical properties in uninjured control tendons were not significantly different, further 141
indicating that postnatal growth was not impaired with TGFβ inhibition (Figure S1 ). Taken together, 142 these data show that TGFβ is required in the first 14 days of healing for functional regeneration. 143 TGFβ signaling in neonatal tenocytes is required for cell recruitment after injury 150
We previously found that Scx-lineage (Scx lin ) tenocyte proliferation, recruitment, and differentiation are 151 unique features of the neonatal regenerative response that are not observed during adult healing 152 (Howell+, Sci Rep, 2017). To first assess whether tenocyte recruitment is affected by TGFβ inhibition, we 153 used the ScxCreERT2 mouse to genetically label differentiated tenocytes prior to injury and traced the 154 fate of these cells during healing when TGFβ signaling is suppressed. In carrier-treated mice, whole 155 mount imaging of hindlimbs showed Scx lin cells (RosaT+) occupying the gap space between the original 156
Achilles tendon stubs at d14 (Figure 3A) , while little RosaT signal was detected in SB-431542-treated 157 limbs ( Figure 3B ). Quantification of transverse sections taken from the midsubstance regions confirmed 158
reduced Scx lin tenocyte numbers with TGFβ inhibition (Figure 3C ,3D) . 159
Since SB-431542 treatment indiscriminantly targets all cells, we next tested whether neonatal tenocytes 160 directly required TGFβ signaling for their recruitment. We therefore deleted TβR2 using ScxCreERT2 161 prior to injury (TβR2 Scx ) and visualized mutant cells by RosaT expression. Since TGFβ signaling is 162 mediated by a single type II receptor (TβR2), all TGFβ signaling is abolished with deletion of this 163
receptor. Consistent with our inhibitor studies, few Scx lin tenocytes were detected in the midsubstance 164
of TβR2 Scx mutant tendons compared to ScxCreERT2 wild type tendons (Figure 3F-3H ). This data suggests 165
that TGFβ signaling is required in neonatal tenocytes for recruitment, rather than an indirect effect of 166
TGFβ inhibition. TGFβ signaling is required for tenocyte migration but not proliferation 176
We hypothesized that the absence of Scx lin cell recruitment at d14 with TGFβ inhibition may be due to a 177 defect in cell proliferation at an earlier timepoint. In a previous study, we showed intense Scx lin tenocyte 178 proliferation that was localized at the cut site of tendon stubs at d3. To test this hypothesis, we collected 179 ScxCreERT2-labeled limbs at d3 post-injury with SB-431542 treatment as well as TβR2 Scx deletion. 180
Consistent with previous findings, transverse sections through the midsubstance gap space confirmed 181
that Scx lin cells were not detectable at d3 after injury for any condition (not shown). EdU staining of 182
proliferating Scx lin tendon cells showed comparable numbers between carrier-treated and SB-431542-183 treated mice after injury (Figure 4A-C) . Similarly, no differences were detected between injured, wild 184 type and TβR2 Scx mutants (Figure 4D-F Since proliferation was not affected, we next determined whether TGFβ signaling may be required for 199 tenocyte migration. In vitro wounds were created in cell monolayers and migration of cells into the 200 defect observed over 12 hours (Figure 5A) . Tenocytes in DMEM alone did not migrate at any timepoint. 201
Differences in wound closure were not observed between DMEM and DMEM+FBS until 12 hours. In 202
contrast, the addition of TGFβ1 significantly enhanced cell migration, and differences in wound closure 203
were detected as early as 4 hours with nearly full wound closure by 8 hours (Figure 5A, B) . 204
Collectively, these results suggest that TGFβ signaling is required in neonatal tenocytes for cell 205 recruitment, and that recruitment occurs by active cell migration rather than growth through 206 proliferation. 207 208 Although Scx lin cells are not present in the gap space at d3, the region is not devoid of cells. At this time, 214 we observed early accumulation of αSMA+ cells that are not from the Scx lin (Howell et al., 2017) . 215 Surprisingly, immunostaining for αSMA revealed that recruitment of αSMA+ cells at d3 was not affected 216
by TGFβ inhibition or TβR2 deletion (Figure 6A, B) . Transverse sections through the midsubstance gap 217 space also confirmed that Scx lin cells were not yet detectable at d3 in any condition (not shown). The 218 presence of αSMA+ cells within the gap space prior to Scx lin cell recruitment suggested that these cells 219 may be a source of TGFβ ligands that signal to tenocytes for migration. Immunostaining for all three 220
TGFβ isoforms showed comparable levels of signal between gap space cells and control tendon ( Figure  221  S3) . We considered the possibility that ligand production may be regulated by TGFβ signaling and that 222
reduced presence of TGFβ ligands may prevent tenocyte recruitment. However, immunostaining for 223
TGFβ ligands showed equivalent staining intensity within the gap space for carrier-and SB-431542-224 treated limbs (Figure S3) . Differences were only observed in injured tendons; we found increased 225 staining of ligands for carrier-treated injured tendons, but this increase was not detected with SB-226 431542 treatment (Figure 7A, B) . This data suggests that TGFβ signaling is required for upregulation of 227
TGFβ ligands with injury, and that this is likely autonomously regulated in tenocytes. Although αSMA+ cells are present at d3, immunostaining showed few αSMA+ cells by d14 for all 241 experimental conditions (Figure S4) , consistent with our previous study (Howell et al., 2017) . We 242 hypothesized that αSMA+ cells (which are not Scx lin ) may differentiate toward the tendon lineage and 243 turn off αSMA. This is supported by previous studies using αSMACreERT2, which showed that αSMA lin 244 cells of the paratenon turn on ScxGFP with adult patellar tendon injury (Dyment et al., 2013) . Analysis of 245
ScxGFP expression in carrier-treated injured limbs indeed showed a population of non-Scx lin , ScxGFP+ 246 cells comprising the neo-tendon (Figure 8A, B) . Comparison to contralateral non-injured controls 247
indicated that incomplete recombination of Scx lin cells does not explain this phenomenon since 248 recombination efficiency is ~96.4% in control tendons. Quantification of the non-Scx lin ScxGFP+ (ScxGFP 249 only) population showed fewer ScxGFP only cells in the neo-tendon after injury in SB-431542-treated 250 mice (Figure 8C-E) . There was a proportional decrease in DAPI+ cells, indicating that the reduction in 251
ScxGFP only cells was probably not due to failure of cells within the gap space to differentiate. Rather, 252
the cells that comprise this population are either not recruited or experience reduced proliferation in 253 the absence of TGFβ signaling. To determine whether these non-Scx lin , ScxGFP+ cells were derived from 254 αSMA+ cells, we used the transgenic αSMACreERT2 mouse and labeled cells by tamoxifen administered 255 at P2, P3. Analysis of transverse cryosections at P5 showed an unexpected amount of recombination in 256
ScxGFP tenocytes (Figure S5) . Immunostaining with anti-αSMA confirmed that neonatal tenocytes 257 normally do not express αSMA. The surprising extent of tendon cell recombination with the 258 αSMACreERT2 therefore precluded its use in identifying the source of non-Scx lin ScxGFP+ cells after 259 injury. 260 To test whether tendon-specific differentiation is affected, we also determined gene expression by real 268 time qPCR at d3 and d14 post-injury. At d3, injured limbs from carrier-treated mice decreased tendon 269 markers Scx, Mkx and Tnmd compared to their contralateral uninjured controls (Figure 9A) . 270 Interestingly, SB-431542-treatment also decreased tendon gene expression in uninjured control tendons 271 relative to carrier controls. Additional decreases with injury were not detected between injured and 272 control tendons with TGFβ inhibition. By d14, tendon gene expression was similar across all samples 273 regardless of treatment or injury (Figure 9B) . Expression levels of Sox9 and Acta2 (the gene for αSMA) 274
were not different across experimental conditions at either timepoint (Figure 9A, B) . These data indicate 275 that despite defects in tenogenic cell recruitment, tendon gene expression after injury was largely not 276 affected by TGFβ inhibition. 277 context of tendon regeneration, it was therefore unclear whether TGFβ would be required for 302 tenogenesis or whether activation of TGFβ would drive fibrotic responses. Using our previously 303 established model of neonatal tendon regeneration, we now show that TGFβ signaling is enhanced after 304 injury and is required in neonatal tenocytes for their recruitment. Since tenocyte proliferation was not 305 affected, we propose that tenocyte-mediated regeneration requires active migration of cells to bridge 306 the gap space. This is further supported by in vitro data showing enhanced migrational capacity of 307 neonatal tenocytes in the presence of TGFβ ligand and is consistent with several studies in the literature 308 for other cell types (Shi & Massague, 2003) . 309
In addition to intrinsic tenocytes, we also identified a second population of non-Scx lin , ScxGFP+ cells that 310 are also recruited to the gap space. Inhibition of TGFβ signaling also resulted in reduced numbers of 311 these cells. One potential source of these cells may be the epitenon as it was previously proposed that 312 tendon stem/progenitor cells reside in epitenon (Dyment et tenocytes at neonatal stages which precluded the use of this line to target epitenon-derived cells. 317
Another source may be nearby vasculature, as CD146+ pericytes have been identified for tendon (Lee et 318 al., 2015) . Despite impaired recruitment of tenogenic cells with TGFβ inhibition, the expression of 319 tenogenic markers Scx, Tnmd, and Mkx were not different at d14. Identifying additional markers for 320 tendon cell fate is the focus of ongoing studies. 321
Unexpectedly, we found that early activation of αSMA+ myofibroblasts is not affected when TGFβ 322 signaling is inhibited. While myofibroblast phenotypes were not expected in TβR2 Scx mutants (since Scx 323 lineage tracing showed that myofibroblasts did not derive from tenocytes), we were surprised to 324 observe abundant myofibroblast accumulation with global SB-431542 inhibition. Since TGFβ signaling is 325 well-established in myofibroblast induction and survival, these results suggest that our inhibition 326 protocol likely did not abrogate all TGFβ signaling and there may be different threshholds required for 327
TGFβ-dependent myofibroblast activation versus tenocyte recruitment. Alternatively, other signaling 328 pathways have also been implicated in myofibroblast activation in the absence of We identified a potential source of TGFβ ligands in myofibroblasts within the gap space, which may 335 drive directional migration of the tenocytes from the stubs. Although abundant TGFβs were also 336 detected in the tendon matrix of uninjured controls, these ligands may be in an inactive state since 337
TGFβs are typically secreted in a latent form bound to the extracellular matrix. Release of TGFβs to its 338 active form can be induced by proteases or mechanically (such as with transection injury) (Maeda et al., 339 2011). We detected an increase in tendon TGFβ ligands after injury, which was suppressed by small 340 molecule inhibition of TGFβ signaling. This suggests that initiation of TGFβ signaling (possibly by release 341
of TGFβs from the matrix with transection) results in positive feedback in tenocytes. Other sources of 342
TGFβs may be immune cells, which are also known to produce TGFβs. Of the three TGFβ isoforms, gene 343 expression data suggested that the primary ligands driving neonatal regeneration may be TGFβs 1 and 3. 344
Although TGFβ1 showed bimodal upregulation pattern, TGFβ3 was consistently upregulated after injury. 345
During embryonic development, TGFβs 2 and 3 are expressed in tendons and allelic deletion of these 346 ligands results in increasing loss of tendons ( 
Gait analysis 428
Mice were gaited at 10 cm/s for 3-4 s using the DigiGait Imaging System (Mouse Specifics Inc., Quincy, 429 MA). A high-speed digital camera was used to capture forelimb paw positions and parameters previously 430 established for mouse Achilles tendon injury were then extracted (Howell+, Sci Rep, 2017). All 431 parameters were normalized to Stride length to account for differences in animal size and age. 432
Biomechanical testing 433
Tensile testing was performed in PBS at room temperature using custom 3D printed grips to secure the 434 calcaneus bone and Achilles tendon (Abraham et al., 2019) . Tendons were preloaded to 0.05N for ~1 435 min followed by ramp to failure at 1%/s. Structural properties were recorded; since cross-sectional area 436 could not be accurately measured due to the small size of the tissues, material properties were not 437 analyzed. 438
Statistical analysis 439
Quantitative results are presented as mean±standard deviation. Two way ANOVA was used for 440 comparisons with two independent variables (injury and TGFβ inhibition); where significance was 441 detected, posthoc testing was then carried out (Graphpad Prism). All other quantitative analyses were 442 analyzed using Students t-tests. Significant outliers were detected using Grubb's test (Graphpad Prism). 443
Sample sizes for gait and mechanical properties quantification were calculated from power analyses 444 with power 0.8 and 5% type I error. Samples sizes for other quantitative data were used based on 445 previous data from the lab and published literature. Significance was determined at p<0.05. 446
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